Danger of multiple use of insulin pen needles for diabetic patients

Aim. To evaluate the risk of multiple use of BD Micro-Fine Plus insulin pen needles in terms of their contamination with microflora, pain and localreaction at the injection site. Materials and methods. The study included 45 patients aged above 18 yr with type 1 and 2 diabetes mellitus (DM1 and DM2...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Inna Vladimirovna Misnikova, Alexander Vasil'evich Dreval', Valeria Alekseevna Gubkina, Irina Vladimirovna Rusanova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2009
Materias:
Acceso en línea:https://doaj.org/article/f97449227819423b805f1ebf3cb9b747
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f97449227819423b805f1ebf3cb9b747
record_format dspace
spelling oai:doaj.org-article:f97449227819423b805f1ebf3cb9b7472021-11-14T09:00:14ZDanger of multiple use of insulin pen needles for diabetic patients2072-03512072-037810.14341/2072-0351-5458https://doaj.org/article/f97449227819423b805f1ebf3cb9b7472009-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5458https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To evaluate the risk of multiple use of BD Micro-Fine Plus insulin pen needles in terms of their contamination with microflora, pain and localreaction at the injection site. Materials and methods. The study included 45 patients aged above 18 yr with type 1 and 2 diabetes mellitus (DM1 and DM2) treated with shortorultrashort-acting insulins TID. Account was taken of the time each needle was used (once, for 4 and 7 days). Microbiological analysis was madeat the respective time points. Pain sensation after injection was evaluated by patients themselves using a visual-analog scale and severity of local reactionsby the physician. Results. Microbial growth was documented in 20 and 33,3% of the patients who used needles ones or many times respectively. Patients of the lattergroup more frequently complained of pain after injection (on day 4, p=0,08) compared with those of the former one (on day 7, p=0,03). Hyperemicfoci at injection sites developed only in case of using the same needle for 4 and 7 days (13,3 and 26,6% respectively). Conclusion. Multiple use of insulin pen needles by patients with DM should be avoided since it leads to hyperemia at injection sites, pain sensation,and risk of microbial contamination.Inna Vladimirovna MisnikovaAlexander Vasil'evich Dreval'Valeria Alekseevna GubkinaIrina Vladimirovna RusanovaEndocrinology Research Centrearticlediabetes mellitusinsulin pensneedlesmicrobial contaminationpainNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 12, Iss 3, Pp 75-77 (2009)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes mellitus
insulin pens
needles
microbial contamination
pain
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes mellitus
insulin pens
needles
microbial contamination
pain
Nutritional diseases. Deficiency diseases
RC620-627
Inna Vladimirovna Misnikova
Alexander Vasil'evich Dreval'
Valeria Alekseevna Gubkina
Irina Vladimirovna Rusanova
Danger of multiple use of insulin pen needles for diabetic patients
description Aim. To evaluate the risk of multiple use of BD Micro-Fine Plus insulin pen needles in terms of their contamination with microflora, pain and localreaction at the injection site. Materials and methods. The study included 45 patients aged above 18 yr with type 1 and 2 diabetes mellitus (DM1 and DM2) treated with shortorultrashort-acting insulins TID. Account was taken of the time each needle was used (once, for 4 and 7 days). Microbiological analysis was madeat the respective time points. Pain sensation after injection was evaluated by patients themselves using a visual-analog scale and severity of local reactionsby the physician. Results. Microbial growth was documented in 20 and 33,3% of the patients who used needles ones or many times respectively. Patients of the lattergroup more frequently complained of pain after injection (on day 4, p=0,08) compared with those of the former one (on day 7, p=0,03). Hyperemicfoci at injection sites developed only in case of using the same needle for 4 and 7 days (13,3 and 26,6% respectively). Conclusion. Multiple use of insulin pen needles by patients with DM should be avoided since it leads to hyperemia at injection sites, pain sensation,and risk of microbial contamination.
format article
author Inna Vladimirovna Misnikova
Alexander Vasil'evich Dreval'
Valeria Alekseevna Gubkina
Irina Vladimirovna Rusanova
author_facet Inna Vladimirovna Misnikova
Alexander Vasil'evich Dreval'
Valeria Alekseevna Gubkina
Irina Vladimirovna Rusanova
author_sort Inna Vladimirovna Misnikova
title Danger of multiple use of insulin pen needles for diabetic patients
title_short Danger of multiple use of insulin pen needles for diabetic patients
title_full Danger of multiple use of insulin pen needles for diabetic patients
title_fullStr Danger of multiple use of insulin pen needles for diabetic patients
title_full_unstemmed Danger of multiple use of insulin pen needles for diabetic patients
title_sort danger of multiple use of insulin pen needles for diabetic patients
publisher Endocrinology Research Centre
publishDate 2009
url https://doaj.org/article/f97449227819423b805f1ebf3cb9b747
work_keys_str_mv AT innavladimirovnamisnikova dangerofmultipleuseofinsulinpenneedlesfordiabeticpatients
AT alexandervasilevichdreval dangerofmultipleuseofinsulinpenneedlesfordiabeticpatients
AT valeriaalekseevnagubkina dangerofmultipleuseofinsulinpenneedlesfordiabeticpatients
AT irinavladimirovnarusanova dangerofmultipleuseofinsulinpenneedlesfordiabeticpatients
_version_ 1718429690158383104